Skip to main content
Clinical Trials/JPRN-UMIN000049566
JPRN-UMIN000049566
Recruiting
未知

Prospective Study to Identify Efficacy, Safety, and Predictors of Tezepelumab in Severe Asthma - J-EAST

Japanese Red Cross Medical Center0 sites30 target enrollmentNovember 20, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
asthma, bronchial asthma
Sponsor
Japanese Red Cross Medical Center
Enrollment
30
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 20, 2022
End Date
December 31, 2027
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients with a history of previous administration of tezepelumab (2\) Patients with serious complications such as cardiac, hepatic, or renal disease (3\) Patients who are judged to be inappropriate for the subject by the physician's judgment.

Outcomes

Primary Outcomes

Not specified

Similar Trials